Details of the Drug Formulation (DFM)
| General Information of DFM (ID: F19469) | |||||
|---|---|---|---|---|---|
| Name |
Ropinirole 2 mg tablet
|
||||
| Company |
Physicians Total Care
|
||||
| Active Pharmaceutical Ingredient (API) | Ropinirole |
API Info
click to show the detail info of this API
|
|||
| Parkinsonism | ICD-11: 8A00 | Approved | |||
| Drug Inactive Ingredient (DIGs) | |||||
| DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
| E0UN4C | DIG Info | Carboxymethylcellulose sodium | Adsorbent ... | ||
| E0NN4I | DIG Info | Dextrin | Binding agent ... | ||
| E0G6HN | DIG Info | Glyceryl behenate | Binding agent ... | ||
| E00DHW | DIG Info | Lactose monohydrate | Binding agent ... | ||
| E01UTP | DIG Info | Magnesium stearate | lubricant | ||
| E0Q6DQ | DIG Info | Mannitol | Diluent ... | ||
| E0Q7IF | DIG Info | Povidone | Binding agent ... | ||
| E01UTV | DIG Info | Silicon dioxide | Anticaking agent ... | ||
| Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
|---|---|---|---|---|---|---|
| Oxidoreductase (ORase) | ||||||
| DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Magnesium stearate | |||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carboxymethylcellulose sodium | |||||
| Biological Activity | EC50 = 12.6 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (3) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Povidone | |||||
| Biological Activity | IC50 = 107 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (4) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Povidone | |||||
| Biological Activity | Protein expression upregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (5) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Silicon dioxide | |||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| DBT Name: Cytochrome P450 2C9 (CYP2C9) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carboxymethylcellulose sodium | |||||
| Biological Activity | EC50 = 113.2 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2C9_HUMAN | |||||
| DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carboxymethylcellulose sodium | |||||
| Biological Activity | EC50 = 373.8 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2CJ_HUMAN | |||||
| DBT Name: Cytochrome P450 3A5 (CYP3A5) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carboxymethylcellulose sodium | |||||
| Biological Activity | EC50 = 83.7 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A5_HUMAN | |||||
| Lyase/isomerase/ligase (L/I/G) | ||||||
| DBT Name: Cholesterol 25-hydroxylase (CYP1A2) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carboxymethylcellulose sodium | |||||
| Biological Activity | IC50 = 224.7 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP1A2_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Povidone | |||||
| Biological Activity | IC50 = 78.3 uM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP1A2_HUMAN | |||||
| Transmembrane channel/porin (TC/P) | ||||||
| DBT Name: Glycine receptor alpha-1 (GLRA1) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Mannitol | |||||
| Biological Activity | EC50 = 12589.25 nM (estimated based on the structural similarity with CHEMBL604608 ) | [3] | ||||
| Structural Similarity | Tanimoto coefficient = 0.804878049 | |||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | GLRA1_HUMAN | |||||
| Cell line (CELL) | ||||||
| DBT Name: Colon cancer Caco-2 cells (Caco-2) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Dextrin | |||||
| Biological Activity | Inhibition ratio > 55 % (tested by experiment) | [4] | ||||
| Tested Species | Homo sapiens (Human) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

